These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792 [Abstract] [Full Text] [Related]
9. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M. J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175 [Abstract] [Full Text] [Related]
12. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy. Malkiewicz JJ, Siuda J. Neurol Neurochir Pol; 2024 Jan; 58(2):193-202. PubMed ID: 38148738 [Abstract] [Full Text] [Related]
13. Free water imaging in Parkinson's disease and atypical parkinsonian disorders. Shah A, Prasad S, Indoria A, Pal PK, Saini J, Ingalhalikar M. J Neurol; 2024 May; 271(5):2521-2528. PubMed ID: 38265472 [Abstract] [Full Text] [Related]
15. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders. Watanabe Y, Suzuki K, Miyamoto T, Miyamoto M, Numao A, Fujita H, Uchiyama T, Kadowaki T, Matsubara T, Hirata K. Intern Med; 2017 Nov 01; 56(21):2871-2878. PubMed ID: 28943542 [Abstract] [Full Text] [Related]
16. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism. Chougar L, Arsovic E, Gaurav R, Biondetti E, Faucher A, Valabrègue R, Pyatigorskaya N, Dupont G, Lejeune FX, Cormier F, Corvol JC, Vidailhet M, Degos B, Grabli D, Lehéricy S. Mov Disord; 2022 Jun 01; 37(6):1245-1255. PubMed ID: 35347754 [Abstract] [Full Text] [Related]
17. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. Han YH, Lee JH, Kang BM, Mun CW, Baik SK, Shin YI, Park KH. J Neurol Sci; 2013 Feb 15; 325(1-2):29-35. PubMed ID: 23260321 [Abstract] [Full Text] [Related]
18. MOBP and HIP1 in multiple system atrophy: New α-synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis. Bettencourt C, Miki Y, Piras IS, de Silva R, Foti SC, Talboom JS, Revesz T, Lashley T, Balazs R, Viré E, Warner TT, Huentelman MJ, Holton JL. Neuropathol Appl Neurobiol; 2021 Aug 15; 47(5):640-652. PubMed ID: 33368549 [Abstract] [Full Text] [Related]